Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANAKINUMAB vs CANRENOATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CANAKINUMAB vs CANRENOATE: Safety Overview

Metric CANAKINUMAB CANRENOATE
Total FAERS Reports 10,462 443
Deaths Reported 518 40
Death Rate 5.0% 9.0%
Hospitalizations 2,624 231
Average Patient Age 28.8 yrs 70.8 yrs
% Female Patients 55.8% 43.5%
Manufacturer Novartis Pharmaceuticals Corporation N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription N/A